聚类分析识别出抗Ku抗体阳性系统性自身免疫病患者的三种临床模式
通过四个免疫科检索抗Ku抗体阳性患者,采用无监督多重对应分析及层次聚类(不纳入疾病诊断)识别出三个聚类。154例患者中,聚类1以肌肉受累和心脏表现为特征,聚类2女性比例最低且肺受累常见,聚类3患者较年轻且多符合系统性红斑狼疮标准。三组预后不同(p=0.001),所有聚类中心脏受累比例随时间倍增。
要点
- 抗Ku抗体阳性患者可分为三个临床聚类,各聚类结局不同(p=0.001)。
- 聚类1肌肉受累常见且疾病进展风险较高,聚类2易发生肌炎,聚类3表现多样。
- 所有聚类中心脏受累比例随时间倍增,结论强调随访中应仔细追踪心脏受累。
核心结论
- 识别出三个不同的抗Ku抗体阳性患者组,所有组在随访中均应仔细追踪心脏受累。
研究设计与样本
- 通过四个免疫科检索抗Ku抗体阳性患者,采用无监督多重对应分析(不纳入疾病诊断)后进行层次聚类,比较各聚类基线特征及疾病进展风险。
主要发现
- 154例抗Ku抗体阳性患者中识别出三个聚类:聚类1(n=42/154,27%)全部有肌肉受累,34%有心脏表现,炎性肌病(n=35/42,83%)和/或系统性硬化(n=17/42,40%)最常见。
- 聚类2(n=69/154,45%)女性比例最低(68%,聚类1和3分别为83%和84%),54%有肺受累,25%符合舍格伦病标准。
- 聚类3(n=43/154,28%)患者较年轻(中位年龄25岁),79%符合系统性红斑狼疮标准。
- 三个聚类结局不同(p=0.001):聚类1发生肺受累且疾病进展风险较高,聚类2易发生肌炎,聚类3出现多种临床表现。
- 所有聚类中心脏受累比例随时间倍增,其中心肌炎多见于聚类1,肺动脉高压多见于聚类2,心包炎多见于聚类3。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine distinct patterns of patients with autoimmune diseases harbouring anti-Ku antibodies and their respective prognosis. METHODS: Anti-Ku-positive patients were retrieved through four immunology departments. Clusters were derived from unsupervised multiple correspondence analysis, not including the disease's diagnosis, followed by hierarchical clustering. Baseline characteristics and risk of disease progression, defined as a composite of new organ involvement or the need for new immunosuppressants, were compared across the retrieved clusters. RESULTS: Among 154 anti-Ku-positive patients, three clusters were identified. At disease's onset, all patients included in cluster 1 (n=42/154, 27%) had muscle involvement, 34% displayed cardiac manifestations. Inflammatory myopathies (n=35/42, 83%) and/or systemic sclerosis (n=17/42, 40%) were the most frequent diagnoses. Cluster 2 (n=69/154, 45%) included the lowest proportion of women (68% vs 83% and 84% in clusters 1 and 3), 54% of patients had lung involvement, and 25% fulfilled Sjögren's disease criteria. Cluster 3 (n=43/154, 28%) included younger patients (median age 25 years), with 79% of them fulfilling systemic lupus erythematosus criteria. These three clusters have distinct outcomes (p=0.001): cluster 1 developed lung involvement and displayed the higher risk of disease progression, cluster 2 was prone to myositis development and cluster 3 developed various clinical manifestations. The proportion of patients with heart involvement doubled over time in all clusters, with a majority of myocarditis in cluster 1, pulmonary hypertension in cluster 2 and pericarditis in cluster 3. CONCLUSION: Three distinct groups of anti-Ku-positive patients were identified; cardiac involvement should be carefully tracked throughout the follow-up in all of them.
引用
- Robert M, Nguyen Y, Allenbach Y, et al. Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies. RMD Open. 2025. PMID: 40473271. doi:10.1136/rmdopen-2024-005191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。